Embargo Watch

Keeping an eye on how scientific information embargoes affect news coverage

FDA back to its old tricks, trying to turn reporters into stenographers

with 2 comments

fdaThe FDA, it would appear, is back to old tricks that it claimed it had ended in 2011.

This weekend, in a column titled “When Sources Set The Ground Rules,” New York Times public editor Margaret Sullivan highlighted an unusual sentence in a story that had appeared in the paper:

SOMETIMES a single sentence can be a window into a world.

Such a sentence appeared in Sabrina Tavernise’s front-page article late last month about the federal Food and Drug Administration’s new guidelines for e-cigarettes. It read: “F.D.A. officials gave journalists an outline of the new rules on Wednesday, but required that they not talk to industry or public health groups until after Thursday’s formal release of the documents.”

That’s a concept that gives many journalists the creeps: the government telling journalists to whom they can and can’t talk.

Sullivan quoted my friend Ira Stoll, writing on his Smarter Times website:

Who gave the F.D.A. the authority to stop journalists from asking questions? Why would any journalist agree to abide by such a requirement? Did The Times agree to it, and if it did agree to it, did it abide by the agreement? What is the F.D.A.’s rationale for such restrictions?

Another Times reporter, Stephanie Strom, told Sullivan:

This is something that never existed before, but now we’re seeing it more and more.

Indeed. The FDA did the same thing in 2011, raising the ire of Embargo Watch and a number of others. One of the groups that raised concerns was the Association of Health Care Journalists, where I am now vice president (and was treasurer in 2011). The AHCJ wrote a letter to the FDA, which responded by saying

A journalist may share embargoed material provided by the FDA with non-journalists or third parties to obtain quotes or opinions prior to an embargo lift provided that the reporter secures agreement from the third-party to uphold the embargo.

Apparently, they’ve reneged on that policy. From Sullivan’s column:

Erica Jefferson, the F.D.A.’s spokeswoman, told me that the motivation was not to be manipulative but to give reporters early access to a complicated news development. Because they were only being briefed, not given the document itself, she said, it wouldn’t have been wise to ask outside experts to comment on something they hadn’t seen. And, she noted, the F.D.A.’s activities are bound by many legal restrictions, and have the ability to move markets; the information has to be handled with care.

“We told reporters that once the document is out, you can update your story” with outside comment, Ms. Jefferson said.

Another government agency, the U.S. Chemical Safety Board, also tried to turn reporters into stenographers earlier this year, but quickly reversed itself after an Embargo Watch post about it.

Sullivan concludes:

Like quote approval, this practice ought to be stomped out. I’d like to see The Times push back — hard — against such restrictions in every instance, and be prepared to walk away from the story if need be.

Amen, for all news organizations.

 

 

 

 

About these ads

Written by Ivan Oransky

May 4, 2014 at 12:18 pm

Posted in Uncategorized

2 Responses

Subscribe to comments with RSS.

  1. Too bad reporters aren’t so ethical when it comes to the Obama Administration in general.

    DocEpador

    May 4, 2014 at 1:01 pm

  2. The FDA has enjoyed a lengthy practice in the regulation, manipulation and censorship of speech. Listen carefully to any commercial for a pharmaceutical product on TV, and you will hear the government speaking. Every verb, every noun in those convoluted sentences has been midwifed in committee. An embargo of a different kind hangs over the construction of these dense, contradictory advertisements. “Say it our way, or you won’t be allowed to say it at all.” Big pharma has fewer principles than journalists, I suppose – they have capitulated en mass.
    So next time you hear, “Do not take bliftixustomab unless you want to die. Lymphomas, tuberculosis, and other cancers have happened” just think – this could have happened to what you were trying to say.

    kirkmike157

    May 4, 2014 at 1:18 pm


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 23,422 other followers

%d bloggers like this: